Effects of Very Low Calorie Diet vs Metabolic Surgery on Weight Loss and Obesity Comorbidities

Catholic University of the Sacred Heart218 enrolled

Overview

It is a prospective randomized trial on 218 subjects, 109 for each arms. The purpose of this trial is to compare very low calorie diet and metabolic surgery induced weight loss and its maintenance.

Obesity is a leading public health issued associated with poor quality of life, morbidity and an increased mortality rate. Although metabolic surgery results in a greater weight loss when compared to non-surgical approaches, a low calorie diet associated with intensive maintenance session may be a valid alternative for weight loss. Since lifestyle interventions are safer and potentially more cost effective than metabolic surgery, this trial will test whether an intensive lifestyle intervention is as effective as metabolic surgery to induce weight loss and its maintenance. A total of 218 participants will be randomly assigned to metabolic surgery (109) or intensive lifestyle intervention (109). Clinical outcomes will be assessed at 25% reduction in Body Mass Index (BMI), at 12 months and 24 months.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

218

Conditions

Obesity, Morbid Obesity Diet, Healthy Bariatric Surgery Candidate

Interventions

Very low calorie diet with Fortimel (Nutricia) supplementationBEHAVIORAL

Patients will undergo a very low calorie diet

Metabolic SurgeryPROCEDURE

Patients will undergo metabolic surgery

Eligibility

Sex: ALLMin age: 19 YearsMax age: 69 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Aged between 19 and 69 years * Body Mass Index ≥35 kg/m2 and at least one or more obesity-related co-morbidities such as type II diabetes (T2DM), hypertension, sleep apnea and other respiratory disorders, non-alcoholic fatty liver disease, osteoarthritis, lipid abnormalities, gastrointestinal disorders, or heart disease * Body Mass Index ≥40 kg/m2 Exclusion Criteria: * Pregnancy * Active cancer * End stage renal failure * End stage liver failure * Being unable to understand and sign informed consent

Locations (1)

Catholic University School of Medicine

Rome, Italy

Outcomes

Primary Outcomes

Time to achieve a 25% reduction in Body Mass Index

Time frame: 1-12 months

Secondary Outcomes

Percentage of participants who achieve 25% reduction in Body Mass Index

Time frame: 1-12 months

Time to achieve 25% reduction in Body Mass Index

Time frame: 1-24months

Change in body composition (lean mass-all tissues in the body except bone and fat-fat mass, bone density and visceral fat) using dual energy X-ray absorptiometry (DXA), from baseline, at 25% weight loss, at 12 months follow up and at 24 months follow up

Time frame: 1-24months

Change in glycated hemoglobin (HbA1c), from baseline, at 12 and 24 months follow up (patients with diabetes)

Time frame: 1-24months

Change in fasting glucose and fasting insulin, from baseline, at 12 and 24 months follow up

Time frame: 1-24months

Change in insulin resistance (assessed by HOMA-IR), from baseline, at 12 and 24 months follow up

Time frame: 1-24months

Change in blood pressure, from baseline, at 12 and 24 months follow up

Time frame: 1-24months

Change in total, HDL, LDL and total cholesterol from baseline, at 12 and 24 months follow up

Time frame: 1-24months

Change in triglycerides from baseline, at 12 and 24 months follow up

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.